Table 2.
Study | Location | Study design | Time period | Study population | Exposure | Exposure assessment | Outcome | Main findings |
---|---|---|---|---|---|---|---|---|
Heavy metals | ||||||||
Lin et al. (2017) [33] | Taiwan | Crosssectional | 2014 | Hospital-based; n=1,137 individuals receiving transabdominal sonography | Heavy metals: arsenic, cadmium, chromium, copper, lead, mercury, nickel, zinc | Residential township linked with survey of soil heavy metal concentrations | NAFLD (n=301) using transabdominal sonography; exclusions for drug history of total parenteral nutrition, long-term use of estrogen, tamoxifen, amiodarone, sodium valproate, methotrexate or corticosteroids | Heavy metals exposures was associated with NAFLD among males (OR 1.83, 95% CI 1.16–2.90) but not females (OR 1.06, 95% CI 0.57–1.96) adjusting for age, BMI, metabolic syndrome, smoking, alcohol consumption, SES |
Hyder et al. (2013) [83] | US | Crosssectional | 1988–1994 | National Health and Nutrition Examination Survey (NHANES) | Heavy metals: cadmium | Creatinine-corrected urinary cadmium | NAFLD (n=1,175 males and n=1,147 females) using gallbladder ultrasound videotapes and ALT or AST levels; exclusions for heavy alcohol consumption or zydovudine or didanosine use | Higher urinary cadmium levels (≥0.65 μg/g for males and ≥0.83 μg/g for females) compared to lower levels were associated with NAFLD among males (OR 1.30, 95% CI 1.01–1.68) but not females (OR 1.11, 95% CI 0.88–1.41) adjusting for age, race/ethnicity, education, smoking, pack years, sedentary lifestyle, BMI, alcohol consumption, total cholesterol |
Trihalomethanes | ||||||||
Burch et al. (2015) [82] | US | Crosssectional | 1999–2006 | NHANES | THM | Blood THM | NAFLD (n=353) using elevated ALT levels (>40 IU/L for males; >30 IU/L for females); exclusions for heavy alcohol consumption, HBV, HCV, self-reported liver cancer, or high transferrin saturation levels | Higher total THM levels (highest tertile mean 62.0 ± 88.9 pg/mL) compared to lower levels (mean 7.4 ± 2.5 pg/mL) were not associated with NAFLD (OR 1.23, 95% CI 0.87–1.72) adjusting for age, race, smoking, BMI, alcohol consumption, selfreported high BP, diastolic BP, total cholesterol, albumin |
Methyl tert-butyl ether | ||||||||
Yang et al. (2016) [84] | China | Crosssectional | 2014 | Petrol station attendants (n=71) | MTBE | Personal exposure monitoring using charcoal-based organic vapor monitor | NAFLD (n=11) using abdominal ultrasonography; exclusions for heavy alcohol consumption, HBV, HCV, autoimmune hepatitis, primary biliary cirrhosis, or other chronic liver disease | Higher MTBE exposure (≥300 μg/m3) compared to lower exposure (≤100 μg/m3) was suggestively associated with NAFLD (OR 1.52, 95% CI 0.93–1.61) adjusting for age, sex, physical activity, BMI, SBP, DBP, ALT, WBC, TC, TG, LDL, HDL |
Selenium | ||||||||
Yang et al. (2016) [85] | China | Crosssectional | 2011–2012 | Shanghai subsample of Risk Evaluation of Cancers in Chinese Diabetic Individuals: a Longitudinal study (REACTION) (n=8,550) | Selenium | Plasma selenium | NAFLD (n=3,732) using ultrasonography; exclusions for heavy alcohol consumption or history of liver disease | Higher selenium levels (>247.4 μg/L) compared to lower levels (<181.6 ug/L) were associated with NAFLD (OR 1.54, 95% CI 1.13–2.18) adjusting for age, sex, BMI, smoking, alcohol consumption, physical activity, waist circumference, SBP, DBP, fasting plasma glucose, post-loading plasma glucose, HOMA-IR, lipid profiles and estimated glomerular filtration rate, ALT, AST, GGT, CRP |
Abbreviations: ALT, alanine aminotransferase; AST, aspartate aminotransferase; BMI, body mass index; CRP, C-reactive protein; DBP, diastolic blood pressure; GGT, gamma-glutamyltransferase; HDL, high-density lipoprotein; HOMA-IR, Homeostatic Model Assessment of Insulin Resistance; LDL, low-density lipoprotein; MTBE, methyl tert-butyl ether; NAFLD, nonalcoholic fatty liver disease; OR, odds ratio; SBP, systolic blood pressure; SES, socioeconomic status; TC, total cholesterol; TG, triglyceride; THM, trihalomethane; WBC, white blood cell.